Regulators in Britain approved another anti-Corona virus vaccine for use in the country on Friday. The Medicines and Healthcare Products Regulatory Agency stated that the single-dose vaccine prepared by Johnson & Johnson met the ‘expected standards of safety, quality and effectiveness’.
After getting the approval to use this vaccine, the number of such vaccines in the country has increased to four, which have been approved. Earlier two-dose vaccines developed by Pfizer / Bioentech, AstraZeneca and the University of Oxford and Moderna were approved.
The regulator said that the vaccine developed by Jensen, a subsidiary of Johnson & Johnson, has been found to be 67 percent effective in preventing Covid-19 infection and 85 percent effective in preventing serious illness or hospitalization. It can be stored at a temperature of 2 to 8 ° C. The regulator said this would make the vaccine ‘ideal for delivery to care units and other places’.
Britain has vaccinated rapidly since December. About 58 percent of the population has been given at least one dose and about 35 percent have received two doses. The UK has seen a slight increase in recent cases of new types of corona vias, which have been considered more infectious than earlier types of the virus.
Second Dose Different Vaccine: Do not panic if you get a different vaccine by mistake in the second dose, Dr. Paul explained the whole thing